PatternsRadar
Sign in

KIMSKrishna Institute of Medical Sciences Limited

NSE
Full chart
693.40INR-12.05 (-1.71%)Close · 6 Oct 2026
3 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹29,123 CrMarket cap
149.8P/E (TTM)
63.1%Delivery

Filings & corporate actions

23 results filed
CSV
Next results · Q2 FY27
Expected 7 Nov 2026 – 12 Nov 2026
Estimate: filed 38–43 days after quarter end, last 5 times
2026
  • 4 AugshareholdingShareholding · 19 Jun 2026-3.0%NSE
  • 3 AugresultsResults · Q1 FY27 · consolidated and standalone-3.0%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+0.2%NSE
  • 15 MayresultsResults · Q4 FY26 · consolidated and standalone-5.9%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+0.5%NSE
  • 6 FebresultsResults · Q3 FY26 · consolidated and standalone+8.7%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-0.5%NSE

Reaction to results · all yearsrose on day 0 in 14 of 22 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY273 Aug 2026-3.0%-0.9%-7.6%2.1×
Q4 FY2615 May 2026-5.9%-0.6%+2.2%0.8×
Q3 FY266 Feb 2026+8.7%+15.0%+15.7%4.7×
Q2 FY267 Nov 2025-3.7%-7.1%-7.1%1.9×
Q1 FY266 Aug 2025+1.8%-1.3%+0.3%2.1×
Q4 FY2512 May 2025+1.2%-1.9%-0.1%1.5×
Q3 FY256 Feb 2025-1.8%-11.1%-21.5%0.6×
Q2 FY259 Nov 2024-1.3%-0.5%+7.3%9.0×
Q1 FY257 Aug 2024+2.4%+8.0%+24.1%2.1×
Q4 FY2417 May 2024+3.2%-3.7%+7.9%0.1×
Q3 FY243 Feb 2024-2.5%-0.9%+3.9%1.1×
Q2 FY247 Nov 2023-0.9%+0.4%+3.8%0.6×
Q1 FY247 Aug 2023-1.8%+2.3%+10.7%4.0×
Q4 FY2319 May 2023+0.1%+4.5%+6.4%2.5×
Q3 FY239 Feb 2023+0.9%-3.7%-3.8%0.7×
Q2 FY2312 Nov 2022+8.9%+2.1%+1.3%10.8×
Q1 FY2311 Aug 2022+1.6%-3.0%-1.4%8.9×
Q4 FY2220 May 2022+0.9%0.0%-9.8%0.3×
Q3 FY2210 Feb 2022+5.7%+1.0%+7.2%2.6×
Q2 FY2211 Nov 2021+3.7%+7.1%+16.8%3.0×
Q1 FY2211 Aug 2021+1.9%+1.3%-0.9%1.5×
Q4 FY213 Jul 2021+7.5%+14.3%+26.4%—
Average+1.2%+1.0%+3.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+35.3%
Profit YoY-56.0%
Interest cost YoY—
Revenue QoQ+9.8%
Profit QoQ+13.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open710.15
Day range691.00 – 711.95
52-week range575.80 – 858.00
From 52w high-19.2%
RSI (14)26.1
ATR (14)24.90
Volume9.14L
Avg volume (20D)6.09L
Rel volume1.50×
Volatility (1Y)31.8%
Turnover₹63.4Cr
SMA 50 / 200780.87 / 720.45

Delivery percentage

Latest · 6 Oct 202663.1%
20-day avg56.0%
1-year avg54.9%
Percentile (own history)73rd
Range16.6–97.9%
Sessions1,304

Over the last 20 sessions KIMS settled 56.0% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 54.9%. The latest session ranks higher than 73% of the 1,304 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHospital
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price-1.71%-9.53%-9.70%-13.93%+10.72%-4.58%

Valuation

CSV
Market cap₹29,123 Cr
P/E (TTM)149.8
EPS (TTM)4.63
Shares outstanding42.00Cr
Listed28 Jun 2021

Ownership

CSV
Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)960.7997.71,074.61,179.5
YoY chg——+34.8%+35.3%
Net profit (₹ Cr)72.051.933.137.4
YoY chg——-68.8%-56.0%
Net margin7.5%5.2%3.1%3.2%
EPS1.671.331.061.04

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 32.50% · public 67.50%
25 Jun 2021: promoter 38.85%30 Sept 2021: promoter 38.84%31 Dec 2021: promoter 38.84%31 Mar 2022: promoter 38.84%30 Jun 2022: promoter 38.84%30 Sept 2022: promoter 38.84%31 Dec 2022: promoter 38.84%31 Mar 2023: promoter 38.84%30 Jun 2023: promoter 38.84%30 Sept 2023: promoter 38.84%31 Dec 2023: promoter 38.82%31 Mar 2024: promoter 38.82%30 Jun 2024: promoter 38.82%30 Sept 2024: promoter 38.82%31 Dec 2024: promoter 38.82%31 Mar 2025: promoter 38.82%30 Jun 2025: promoter 34.11%30 Sept 2025: promoter 34.11%31 Dec 2025: promoter 34.11%31 Mar 2026: promoter 34.11%19 Jun 2026: promoter 32.50%30 Jun 2026: promoter 32.50%
2021-062026-06
  • Promoter
  • Public and others
Promoter
32.50%
Public
67.50%
Promoter change
0.00 pp
Filed
21 Jul 2026
FII
14.74%
DII
34.43%
Promoter pledged
10.26%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations652.5605.8633.8688.4777.3772.4796.9871.6960.7997.71,074.61,179.5
Other income2.93.33.84.65.017.84.57.14.25.29.716.4
Total income655.4609.1637.6693.0782.3790.2801.4878.7964.91,002.91,084.31,195.9
Total expenses516.7506.5537.5565.9620.1655.6678.2765.0867.8934.31,021.21,140.3
└ Finance costs8.912.416.417.919.925.726.732.645.056.868.183.4
└ Depreciation32.635.446.339.041.044.752.653.466.178.785.0100.8
Profit before tax138.6102.6100.1127.1162.2134.6134.0113.796.868.652.255.6
Tax expense37.325.928.531.941.542.127.928.724.816.721.719.2
Net profit101.376.671.595.2120.792.5106.185.072.051.933.137.4
EPS2.301.801.642.162.682.222.541.961.671.331.061.04
Net margin15.52%12.64%11.28%13.83%15.53%11.98%13.31%9.75%7.49%5.20%3.08%3.17%
PBT margin21.24%16.93%15.80%18.46%20.87%17.43%16.82%13.04%10.08%6.88%4.86%4.71%
Tax rate26.92%25.25%28.47%25.10%25.59%31.28%20.82%25.24%25.62%24.34%41.57%34.53%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 3 Aug 2026.

KIMS at a glance

  • KIMS closed at ₹693.4 on 6 Oct 2026, -1.71% on the day, -4.6% over one year, 19.2% below its 52-week high of ₹858.
  • Delivery was 63.1% of traded quantity on 6 Oct 2026, the 73rd percentile of its own 1,304 sessions with a reading (20-session average 56.0%, 1-year average 54.9%).
  • Market capitalisation is ₹29,123 crore at a trailing P/E of 149.8 (trailing EPS ₹4.63).
  • Q1 FY27 results (consolidated, filed 3 Aug 2026): revenue ₹1,180 crore (+35.3% year on year), net profit ₹37 crore (-56.0%); the price moved -3.0% on the first session after.
  • Promoters held 32.50% at 30 Jun 2026, unchanged on the previous filing, with 10.26% of promoter shares pledged.
  • Q2 FY27 results are expected between 7 Nov 2026 and 12 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHospital
ISININE967H01025
SeriesEQ
Listed28 Jun 2021
History from28 Jun 2021
Sessions1,308
Turnover rank#501

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE